DeHeng Assisted bioGenous in Completing Series A+ Financing, Raising Tens of Millions of Yuan

2025-01-07

Recently, bioGenous BIOTECH Inc., announced the completion of a Series A+ financing round, raising tens of millions of yuan from the sole investor AstraZeneca CICC Medical Industry Fund of Funds. The money raised will primarily be used for market expansion both domestically and internationally, construction of production bases, and development of innovative technologies, aiming to provide globally leading organoid full-process solutions.

As the legal advisor for bioGenous, the DeHeng, with primary support from partners Zhang Lei and Fang Wen and lawyer Shang Shuali, provided full-process legal services for this project.